Your browser doesn't support javascript.
loading
Vascular Effects of ACE (Angiotensin-Converting Enzyme) Inhibitors and Statins in Adolescents With Type 1 Diabetes.
Chiesa, Scott T; Marcovecchio, M Loredana; Benitez-Aguirre, Paul; Cameron, Fergus J; Craig, Maria E; Couper, Jennifer J; Davis, Elizabeth A; Dalton, R Neil; Daneman, Denis; Donaghue, Kim C; Jones, Timothy W; Mahmud, Farid H; Marshall, Sally M; Neil, H Andrew W; Dunger, David B; Deanfield, John E.
Afiliação
  • Chiesa ST; From the Institute of Cardiovascular Science, University College London, United Kingdom (S.T.C., J.E.D.).
  • Marcovecchio ML; Department of Paediatrics (M.L.M., D.B.D.), University of Cambridge, United Kingdom.
  • Benitez-Aguirre P; Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, University of Sydney, Camperdown, Australia (P.B.-A., K.C.D.).
  • Cameron FJ; Department of Paediatrics, University of Melbourne, Australia (F.J.C.).
  • Craig ME; School of Women's and Children's Health, University of New South Wales, Australia (M.E.C.).
  • Couper JJ; Departments of Endocrinology and Diabetes, Women's and Children's Hospital, Robinson Research Institute, University of Adelaide, Australia (J.J.C.).
  • Davis EA; Telethon Kids Institute, University of Western Australia, Perth (E.A.D., T.W.J.).
  • Dalton RN; Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom (R.N.D.).
  • Daneman D; Department of Paediatrics, The Hospital for Sick Children, University of Toronto, ON, Canada (D.D., F.H.M.).
  • Donaghue KC; Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, University of Sydney, Camperdown, Australia (P.B.-A., K.C.D.).
  • Jones TW; Telethon Kids Institute, University of Western Australia, Perth (E.A.D., T.W.J.).
  • Mahmud FH; Department of Paediatrics, The Hospital for Sick Children, University of Toronto, ON, Canada (D.D., F.H.M.).
  • Marshall SM; Institute of Cellular Medicine (Diabetes), Faculty of Clinical Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom (S.M.M.).
  • Neil HAW; Oxford Centre for Diabetes, Endocrinology, and Metabolism, University of Oxford, United Kingdom (H.A.W.N.).
  • Dunger DB; Department of Paediatrics (M.L.M., D.B.D.), University of Cambridge, United Kingdom.
  • Deanfield JE; Wellcome Trust-MRC Institute of Metabolic Science (D.B.D.), University of Cambridge, United Kingdom.
Hypertension ; 76(6): 1734-1743, 2020 12.
Article em En | MEDLINE | ID: mdl-33100044

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Enzima Conversora de Angiotensina / Endotélio Vascular / Inibidores de Hidroximetilglutaril-CoA Redutases / Diabetes Mellitus Tipo 1 / Rigidez Vascular Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Enzima Conversora de Angiotensina / Endotélio Vascular / Inibidores de Hidroximetilglutaril-CoA Redutases / Diabetes Mellitus Tipo 1 / Rigidez Vascular Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article